Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]

Biosimilar medicines: Increasing access to modern essential medicines while supporting sustainability of healthcare systems

16 February 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Biosimilar medicines. Essential for increasing access to important medicines and the sustainability of healthcare systems

25 January 2017

Biologic medicines have revolutionised the management of many serious diseases […]

The global scourge of counterfeit medicines

8 November 2016

The statistics are truly disturbing, with an annual death toll […]

Commission to Look into ‘Skyrocketing’ EU Drug Prices, Availability, and Patient Access

20 June 2016

Medicines for Europe: Better Access, Better Health

1 March 2016

EGA Prioritises Pursuing Sustainability Agreements

12 February 2016

Les génériques rament pour accéder au marché

7 October 2015

A Comprehensive And Fair Solution To The Price Of Medicines

7 October 2015

After a long dry spell, the pharmaceutical research industry has […]